DUBLIN--(BUSINESS WIRE)--The "Drug Discovery Technologies Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global drug discovery technologies market to grow with a CAGR of 18.4 % over the period of 2018 - 2024.
The report on drug discovery technologies market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global drug discovery technologies market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's Five Forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global drug discovery technologies market over the period of 2016 - 2024. Further, the author's Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Segments Covered
The global drug discovery technologies market is segmented on the basis of technology type, and end users.
Global Drug Discovery Technologies Market by Technology Type
- Biochips
- High throughput screening
- Pharmacogenomics
- Genomics
- Bioanalytical instruments
- Bioinformatics
- Nanotechnology
- Others (RNAi, combinatorial chemistry)
Global Drug Discovery Technologies Market by End Users
- Biopharmaceutical companies
- Pharmaceutical companies
- Research institutes
- Biotech companies
Global Drug Discovery Technologies Market by Regions
- North America
- Europe
- Asia-Pacific
- RoW
Companies Profiled
- Agilent Technologies, Inc
- Abbott Laboratories, Inc.
- GE Healthcare Ltd.
- Albany Molecular Research Inc.
- Affymetrix Inc.
- Arqule Inc.
- Luminex Corporation
- Bayer Healthcare AG
- Novartis AG
-
Astrazeneca plc
For more information about this report visit https://www.researchandmarkets.com/research/nggdfl/drug_discovery?w=4
